20 octubre 2014
Selenium, when attached to a monoclonal antibody presently used to treat breast cancer, has shown greater success in destroying cancer cells in a patient who has developed resistance to the chemotherapy, research demonstrates. Almost a quarter of a million people were diagnosed with breast cancer this year, while another 3 million are living with the disease.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/7yO_TYoSig4/141020121408.htm
